Skip to main content


U.S. flag
      An official website of the United States government
              Here’s how you know
        Here’s how you knowDot gov**Official websites use .gov**
                 A **.gov** website belongs to an official government organization in the United States.
                  HTTPS**Secure .gov websites use HTTPS**
                 A **lock** (A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. 
  Menu Close
          HHS Search block
    Search
        








  
  
    

  
      

                                      About HHS
    
                        
                              
      
      
      Programs & Services
    
                        
                              
      
      
      Grants & Contracts
    
                        
                              
      
      
      Laws & Regulations Breadcrumb
    Home
                              Blog
                              The National Vector-Borne Disease Framework and LymeX Innovation
 Navigate to:
  Categories
    Coronavirus (12)
        Health IT (13)
        Fraud (1)
        Grants and Contracts (1)
        Research (5)
        Prevention and Wellness (21)
        Health Data (6)
        Holidays and Observances (17)
        Global Health (4)
        Public Health and Safety (28)
        HIPAA (4)
        Programs for Families and Children (6)
        Americans with Disabilities Act (1)
        Mental Health and Substance Abuse (1)
        Vaccines (1)
        HHS Administrative (4)
        LGBT (1)
        Emergency Preparedness and Response (1)
        Drug Pricing (5)Text resize icon

                    




The National Vector-Borne Disease Framework and LymeX Innovation Updates








  
  
    

  
      
**June 1, 2021**
                |
        By:  Kristen    Honey  PhD, PMP, Chief Data Scientist and Senior Advisor and Leith    States  M.D., MPH., Acting Director, Office of Science and Medicine, OASH

  
**Summary:**
  





As part of the interagency development of a national strategy on vector-borne diseases, HHS is accelerating progress with its LymeX Innovation Accelerator


      In response to the Kay Hagan Tick Act of 2019, HHS is collaborating across the federal government to create an interagency national strategy with vector-borne disease objectives, activities, performance metrics, and a coordination and monitoring plan. This includes tick-borne diseases like Lyme disease.

As part of this greater federal effort on vector-borne diseases, HHS and the Steven & Alexandra Cohen Foundation launched the LymeX Innovation Accelerator (LymeX) to accelerate Lyme Innovation progress and address the growing magnitude of Lyme disease and its serious impact on the American people. The LymeX partnership has bold goals for innovation, disrupting the status quo, and changing the Lyme disease landscape. The HHS Tick-Borne Disease Working Group (TBDWG) also contributed the recently published 2020 TBDWG Report to Congress.

**Background of the National Public Health Framework for the Prevention and Control of Vector-Borne Diseases in Humans**

A National Public Health Framework for the Prevention and Control of Vector-Borne Diseases in Humans


Multiple federal agencies collaborated to develop the National Vector-Borne Disease Framework, published by the Centers for Disease Control and Prevention (CDC) in September 2020. This framework identifies seven goals with strategic priorities and federal agency roles, providing a preliminary high-level framework with essential vector-borne guidance, and shows exactly why the LymeX partnership is so valuable right now.

**How we will Implement the Goals of the Framework**

In collaboration with many agencies and collaborators, we plan to achieve multiple goals of the framework, which directly informs the LymeX approach and activities.

**Better understand when, where, and how people are exposed to and get sick or die from vector-borne diseases**
	 
	The Health+ engagement model is critical to help identify risk factors through detailed interviews with patients. Crowdsourcing is also an integral part of how we engage people in the process. We will develop personas and disease profiles to understand Lyme disease’s impact from the patient perspective.
	**Develop, evaluate, and improve tools and guidance for the diagnosis and detection of vector-borne diseases**
	 
	We’re adding an element of competition to jumpstart ideas for new diagnostic tests. The prize challenges will breathe life into new guidelines for Lyme disease diagnosis and management. We will leverage existing investments in sample Lyme biorepositories ("biobanks"). Those repositories will provide valid scientific evidence and support participants’ development of new tools.
	**Develop, evaluate, and improve tools and guidance for the prevention and control of vector-borne diseases**
	 
	Through Health+ and crowdsourcing with HHS open innovation methods, we will identify and share evidence to support vector-borne disease prevention guidelines. We will invite the public to share their ideas, develop new apps and tools, communicate critical information, and raise awareness about Lyme disease and tick-borne diseases.
	**Disseminate and support the implementation of effective public health vector control products, tools, and programs to prevent, detect, diagnose, and respond to vector-borne disease threats**
	 
	We will raise awareness about Lyme disease to at-risk people and communities. As the LymeX partnership demonstrates progress, it can serve as a model for other public-private partnerships.With the framework guiding us as our true north, we’re announcing the next step – HHS has issued a Request for Information (RFI) to solicit public input regarding strategic goals, benchmarks, gaps, and opportunities to enhance coordination, data collection, research, and the development of diagnostics, treatments, vaccines and other related activities across HHS and other federal departments. We encourage public comments to be submitted online via the Federal Register or at https://www.regulations.gov/commenton/HHS-OASH-2021-0012-0001. Your comments will be essential in co-creating the development of a national strategy. Thank you for joining us to change the status quo for Lyme and other vector-borne diseases.
  Posted In:
  Public Health and Safety
Tagged:
  Public Health and SafetySign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases

Sign Up







  Subscribe to RSS
    

      Receive latest updates

                    
  


Related Blog Posts
    

      Change Story: Cheryl R. Campbell
  

Change Story: Tiffany Brown
  

Change Story: Robin D. Bailey Jr. Back to top
    Contact HHS
    
                        
                                            
      
      
      Careers
    
                        
                                            
      
      
      HHS FAQs
    
                        
                                            
      
      
      Nondiscrimination NoticeHHS Archive
    
                        
                                            
      
      
      Accessibility Statement
    
                        
                                            
      
      
      Privacy Policy
    
                        
                                            
      
      
      Viewers & PlayersBudget/Performance
    
                        
                                            
      
      
      Inspector General
    
                        
                                            
      
      
      Web Site Disclaimers
    
                        
                                            
      
      
      EEO/No Fear ActFOIA
    
                        
                                            
      
      
      The White House
    
                        
                                            
      
      
      USA.gov
    
                        
                                            
      
      
      Vulnerability Disclosure Policy
        Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases.

Sign Up
  HHS Headquarters
          200 Independence Avenue, S.W.
                  Washington, D.C. 20201
                  Toll Free Call Center: 1-877-696-6775​ Disclaimer Policy: Links with this icon () mean that you are leaving the HHS website. The Department of Health and Human Services (HHS) cannot guarantee the accuracy of a non-federal website.
                  Linking to a non-federal website does not mean that HHS or its employees endorse the sponsors, information, or products presented on the website. HHS links outside of itself to provide you with further information.
                  You will be bound by the destination website's privacy policy and/or terms of service when you follow the link.
                  HHS is not responsible for Section 508 compliance (accessibility) on private websites. For more information on HHS's web notification policies, see Website Disclaimers.
 Continue
                  Go back